Gastrointestinal Cancer: Pathogenesis, Carcinogenesis and Targeted Therapies
Submission Deadline: 20 Mar 2024
Guest Editor
Special Issue Information
Dear Colleagues,
Improved therapeutic strategies for gastrointestinal cancer can be developed through a comprehensive transdisciplinary approach. Colorectal cancer, for example, can be examined microscopically using small tissue sections obtained from the tumor core (tissue microarray,TMA). This is not possible with gastric cancer, however, due to the highly variable tissue architecture and molecular profile. The aim of this special issue is to collect papers that focus on understanding gastrointestinal cancers from the oral mucosa to the anal canal based on experimental, in vivo and ex-vivo studies. All types of research that result in a better understanding of cancer could lead to findings with a prognostic or predictive impact. Research that presents data on primary or metastatic tumors from the liver and pancreas are also welcome. The overall aim of this special issue is therefore to provide an update on the tumorigenesis and targeted therapy of heterogeneous cancers.
Dr. Simona Gurzu
Guest Editor
Keywords
- gastric
- colorectal
- hepato-billiary
- pancreatic cancer
- carcinogenesis
- metastasis
- tumor microenvironment
- targeted therapy
- cell cultures
- heterogeneity
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (5)
Unraveling the Role of TP53 in Colorectal Cancer Therapy: From Wild-Type Regulation to Mutant
Front. Biosci. (Landmark Ed) 2024, 29(7), 272; https://doi.org/10.31083/j.fbl2907272
(This article belongs to the Special Issue Gastrointestinal Cancer: Pathogenesis, Carcinogenesis and Targeted Therapies)
Comprehensive Analysis of the Expression of Cell Adhesion Molecules Genes in Hepatocellular Carcinoma and their Prognosis, and Biological Significance
Front. Biosci. (Landmark Ed) 2024, 29(2), 76; https://doi.org/10.31083/j.fbl2902076
(This article belongs to the Special Issue Gastrointestinal Cancer: Pathogenesis, Carcinogenesis and Targeted Therapies)
miR-330-5p Suppress Cell Growth and Invasion via Disrupting HSF4-mediated MACC1/STAT3 Pathway in Colorectal Cancer
Front. Biosci. (Landmark Ed) 2024, 29(2), 53; https://doi.org/10.31083/j.fbl2902053
(This article belongs to the Special Issue Gastrointestinal Cancer: Pathogenesis, Carcinogenesis and Targeted Therapies)
Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic Aspects
Front. Biosci. (Landmark Ed) 2024, 29(2), 52; https://doi.org/10.31083/j.fbl2902052
(This article belongs to the Special Issue Gastrointestinal Cancer: Pathogenesis, Carcinogenesis and Targeted Therapies)
O-glycoprofiling of Serum Apolipoprotein C-III in Colorectal Cancer
Front. Biosci. (Landmark Ed) 2024, 29(1), 32; https://doi.org/10.31083/j.fbl2901032
(This article belongs to the Special Issue Gastrointestinal Cancer: Pathogenesis, Carcinogenesis and Targeted Therapies)
